AlphaFold vs. ESMFold vs. RFdiffusion: Which Protein AI Tool Do You Need?
AlphaFold, ESMFold, and RFdiffusion are often mentioned together but address fundamentally different problems. This page explains what each one actually does and which task each is built for.
The short answer
These three tools are not competing alternatives — they address different tasks. AlphaFold predicts the structure of a protein whose sequence you already have. ESMFold does the same thing much faster but with lower accuracy. RFdiffusion generates entirely new protein sequences designed to fold into a target structure or perform a target function. Knowing which task you have determines which tool you need.
What each one actually does
| Tool | Task | Input | Output |
|---|---|---|---|
| AlphaFold 3 | Structure prediction | Protein sequence(s); optionally ligands, DNA/RNA | 3D structure + confidence scores (pLDDT, PAE) |
| ESMFold | Structure prediction (fast) | Protein sequence | 3D structure + confidence scores |
| RFdiffusion | Protein design / generation | Target structure, binding site, or design constraints | New protein sequence designed to meet those constraints |
AlphaFold — the gold standard for structure prediction
AlphaFold (developed by Google DeepMind) predicts the 3D structure of a protein from its amino acid sequence. AlphaFold 2 (2021) was the watershed result; AlphaFold 3 (2024) extended this to multi-chain complexes, protein-ligand interactions, nucleic acids, and modified residues.
Use it when: You have a sequence and need to know what the protein looks like in 3D — to understand its function, identify binding sites, guide mutagenesis, or as a starting point for drug discovery.
Key strengths:
- Best accuracy of any structure prediction tool across the board
- AlphaFold 3 handles full complexes: protein-protein, protein-DNA, protein-small molecule
- The AlphaFold Protein Structure Database covers ~200 million proteins — your target may already be there
Key limitations:
- Slower than ESMFold for high-throughput screening of many sequences
- Confidence scores (pLDDT) are high for well-folded regions but structurally disordered regions are flagged; don’t assume every predicted structure is reliable — check pLDDT
- AlphaFold predicts one static conformation; it does not model dynamics or conformational change
Access: AlphaFold Server (free, web-based for standard prediction); open-source code for local installation; pre-computed database via EMBL-EBI.
ESMFold — structure prediction at scale
ESMFold (from Meta AI) is a single-sequence structure prediction model — it does not use multiple sequence alignments (MSAs) as AlphaFold does, which makes it dramatically faster. Published in Science (2022), it can predict hundreds of structures per hour on a single GPU.
Use it when: You need to predict structures for many thousands of sequences (e.g., screening a large protein library, annotating a metagenomic dataset) and can accept somewhat lower accuracy per prediction.
Key strengths:
- ~60× faster than AlphaFold at structure prediction because it skips the MSA step
- Scales to very large protein sets where AlphaFold’s throughput would be prohibitive
- Available via Hugging Face transformers and ESM GitHub repo for local deployment
Key limitations:
- Accuracy is measurably lower than AlphaFold, especially for proteins with distant homologs where MSA provides signal
- Single-sequence only — cannot predict multi-chain complexes or protein-ligand interactions (AlphaFold 3 handles these)
- Not the right tool when you need the most accurate structure for a specific target
Access: Open-source (MIT license) via Meta’s ESM GitHub repository and Hugging Face; no hosted inference API from Meta.
RFdiffusion — designing new proteins from scratch
RFdiffusion (from the Baker Lab, University of Washington) is a generative model for protein design. It doesn’t predict what a known sequence folds into — it generates new protein sequences specifically designed to fold into a target structure or bind a target molecule. Combined with ProteinMPNN (which designs sequences to fold into a generated backbone) and AlphaFold (which validates the predicted structure), it forms a complete de novo protein design pipeline.
Use it when: You want to design a protein that doesn’t exist in nature — a binder for a therapeutic target, a scaffold with a specific geometric shape, an enzyme with a designed active site.
Key strengths:
- Has produced experimentally validated de novo binders, scaffolds, and functional proteins across multiple published studies
- Can incorporate design constraints: target binding site geometry, symmetry, motif grafting
- Open-source (available on GitHub) and runs on GPU
Key limitations:
- Experimental validation rate is still low — many designed proteins don’t fold or function as predicted; design is a numbers game requiring experimental screening
- Requires GPU infrastructure and comfort with a command-line ML pipeline; not a point-and-click tool
- The full pipeline (RFdiffusion → ProteinMPNN → AlphaFold validation → wet-lab testing) is multi-step and requires expertise at each stage
Access: Open-source via RoseTTAFold Diffusion GitHub repository (IPD, UW).
Head-to-head: when to use which
| Scenario | Tool |
|---|---|
| “I have a gene sequence and need the protein structure” | AlphaFold |
| “I need to predict structures for 50,000 sequences by next week” | ESMFold |
| “I need a protein that binds to this receptor pocket” | RFdiffusion + ProteinMPNN + AlphaFold (validation) |
| “I need protein-DNA or protein-ligand complex structure” | AlphaFold 3 |
| “I want to check if my protein is likely disordered” | Either AlphaFold or ESMFold (check pLDDT) |
| “I want to redesign a protein scaffold to improve stability” | RFdiffusion |
Honest limitations that apply to all three
- None replace experimental validation. Predicted structures are models, not facts. For drug discovery or functional claims, crystallography, cryo-EM, or NMR validation is still required.
- Disordered regions are unreliable. All three tools produce low-confidence predictions for intrinsically disordered regions — these are flagged by confidence scores (pLDDT < 70 in AlphaFold) but easy to overlook.
- De novo design (RFdiffusion) has a low experimental success rate. This is normal for the field and improving — but plan for multi-round screening, not first-attempt success.